Else sees Israeli fund renew tender for five years

Executive Summary

• Else Nutrition Holdings Inc. secured a five-year renewal of a tender with Israel's largest health fund for its baby feeding accessory line.
• The contract represents approximately 7% of the company's 2024 revenue and eliminates potential revenue risk from its Israeli business unit.
• The agreement ensures the continued nationwide supply of sterile and non-sterile baby bottles and disposable nipples to hospitals and maternity wards across Israel.

Key Details

• Contract Term: Five-year renewal.
• Counterparty: Israel's largest health fund.
• Revenue Impact: The contract represents approximately 7% of Else Nutrition's 2024 revenue.
• Products Supplied: Sterile and non-sterile baby bottles and disposable nipples.
• End Users: Hospitals and maternity wards across Israel.
• Supply Chain: Products are produced through established third-party manufacturing partners in Europe and Asia and supplied to institutional clients through independent logistics providers.
• Strategic Impact: Reinforces the company's long-standing leadership in hospital-grade infant feeding solutions and secures continued supply.

Notable Quotes

• "This renewal underscores the trust placed in Else's quality, reliability and standards of care," said Hamutal Yitzhak, co-founder and chief executive officer of Else Nutrition. "We are proud to continue serving Israeli hospitals and families at the earliest and most critical moments of life."